EpiPen Buyers Lose Bid For Class Status In ERISA Suit

By Lauren Berg · August 5, 2020, 5:50 PM EDT

A Minnesota federal judge denied class certification to EpiPen buyers Wednesday in a suit accusing Express Scripts, CVS Health and other pharmacy benefit managers of violating the Employee Retirement Income Security...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Order

Case Information

Case Title

In re EpiPen ERISA Litigation (Klein et al v. Prime Therapeutics, LLC et al)

Case Number

Court

Minnesota

Nature of Suit

Labor: E.R.I.S.A.

Date Filed

June 02, 2017

Recent Articles By Lauren

April 25, 2025
Sutter Health To Pay $228M In Years-Old Antitrust Suit
April 18, 2025
Walgreens To Pay DOJ $300M Over Invalid Prescriptions
April 14, 2025
FTC Joins DOJ In Targeting Anticompetitive Regulations
April 11, 2025
Express Scripts Judge Asks If Khan's FTC Exit Affects Suit
April 09, 2025
2nd Circ. Allows Takeda To Appeal Actos Antitrust Class Cert.
April 08, 2025
UnitedHealth Puts Anesthesiologists' Antitrust Suit To Sleep
April 02, 2025
GoodRx, PBM Price-Fixing MDL Set In Rhode Island
March 27, 2025
Oura Gets Samsung's Preemptive IP Strike Tossed, For Now
March 25, 2025
Ex-Masimo CEO Slams Bid To DQ His Hueston Hennigan Attys
March 24, 2025
Children's Hospital Axes Suit Over Meta Info Sharing, For Now